GCC Nursing Guide – Septic Shock Management

📖 Sepsis-3 Definitions (2016, Current Standard)

Sepsis

Life-threatening organ dysfunction caused by a dysregulated host response to infection. Operationalised by an acute change in total SOFA score ≥2 points (presumed baseline SOFA = 0 in absence of known prior organ dysfunction).

Septic Shock

Subset of sepsis where underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality. Defined by: vasopressor requirement to maintain MAP ≥65 mmHg AND serum lactate >2 mmol/L in the absence of hypovolaemia. Hospital mortality >40%.

Infection

A pathologic process caused by invasion of normally sterile tissue, fluid, or body cavity by pathogenic micro-organisms. Does NOT require culture positivity — clinical diagnosis is accepted.

⚠️ The term "severe sepsis" has been retired with Sepsis-3. Sepsis is already life-threatening by definition.

📊 SOFA Score — Full Components

Sequential Organ Failure Assessment (SOFA) quantifies organ dysfunction. Each system scored 0–4. Total score ≥2 with suspected infection = sepsis.

System	Score 0	Score 1	Score 2	Score 3	Score 4
Respiratory PaO₂/FiO₂ mmHg	≥400	300–399	200–299	<200 + vent support	<100 + vent support
Coagulation Platelets ×10³/µL	≥150	100–149	50–99	20–49	<20
Liver Bilirubin µmol/L	<20	20–32	33–101	102–204	>204
Cardiovascular MAP / vasopressors	MAP ≥70	MAP 60–69	Dopa ≤5 or Dobu	Dopa >5 or NAdr/Adr ≤0.1	Dopa >15 or NAdr/Adr >0.1
CNS GCS	15	13–14	10–12	6–9	<6
Renal Creatinine µmol/L or UO	<110	110–170	171–299	300–440 or UO <0.5 mL/kg/hr	>440 or UO <0.2 mL/kg/hr

SOFA 0–6 = Low Risk SOFA 7–9 = Moderate SOFA ≥10 = High Mortality

⚡ qSOFA — Bedside Screening Tool

Quick SOFA (qSOFA) is a rapid bedside screening tool for patients outside ICU suspected of infection. Requires no laboratory results.

Criterion 1

RR ≥ 22

breaths/min

Criterion 2

Altered Mentation

GCS <15 / confusion

Criterion 3

SBP ≤ 100

mmHg

Score ≥2 = high risk of poor outcome → prompt clinical review, consider SOFA assessment, escalate urgently. qSOFA is a screening not a diagnostic tool.

📋 Surviving Sepsis Campaign 2021 — Key Updates

Hour-1 Bundle replaced the previous 3-hour and 6-hour bundles — earlier action is now mandated
Balanced crystalloids (Hartmann's / Lactated Ringer's) recommended over 0.9% NaCl for initial resuscitation
Dynamic fluid responsiveness assessment preferred over static measures (CVP) to guide ongoing fluid therapy
Noradrenaline remains first-line vasopressor; vasopressin or adrenaline added as second-line agents
Hydrocortisone 200 mg/day recommended when noradrenaline ≥0.25 mcg/kg/min (ADRENAL trial evidence)
Blood glucose target 7.8–10 mmol/L — avoid hypoglycaemia
Early initiation of enteral nutrition within 24–48 hours if haemodynamically stable
Procalcitonin-guided antibiotic de-escalation supported to reduce duration of therapy
Stress ulcer prophylaxis only for patients with high-risk factors (not universally)

⚠️ Sepsis Mimics — Do Not Miss

Adrenal Crisis

Hypotension refractory to fluids, hyponatraemia, hyperkalaemia, hypoglycaemia. Often precipitated by missed steroid dose or illness in steroid-dependent patient.

Pulmonary Embolism

Tachycardia, hypoxia, haemodynamic compromise. May mimic septic shock. Wells score, D-dimer, CTPA required for differentiation.

Anaphylaxis

Acute distributive shock with urticaria, angioedema, bronchospasm. Exposure history critical. Treat with adrenaline IM NOT vasopressors first.

Cardiogenic Shock

Elevated JVP, pulmonary oedema, cool peripheries. Troponin, ECG, echo. Excess fluids harmful — cautious resuscitation.

Thyroid Storm

Fever, tachycardia, altered mental status in hyperthyroid patient. May co-exist with infection. TFT essential.

Toxic Shock Syndrome

Staphylococcal or streptococcal exotoxin-mediated. Diffuse erythematous rash, multi-organ failure. Source control critical.

💧 Crystalloid Selection

Balanced Crystalloids (PREFERRED)

Hartmann's / Lactated Ringer's / Plasmalyte
Composition closer to plasma. Avoids hyperchloraemic acidosis. Associated with lower rates of AKI and RRT requirement (SMART, SALT-ED trials).

0.9% NaCl (Avoid as primary)

Normal Saline
High chloride load (154 mEq/L vs plasma 103 mEq/L). Large volumes cause hyperchloraemic metabolic acidosis, renal vasoconstriction, increased AKI risk. Reserve for specific indications (e.g., hypochloraemia, TBI).

Note: Hartmann's contains lactate — in lactic acidosis, do not confuse fluid lactate with serum lactate rise. Serum lactate measurement reflects endogenous production.

📊 Fluid Responsiveness Assessment

After initial 30 mL/kg bolus, use dynamic measures to guide further fluid administration. Static measures (CVP, PAWP) are unreliable predictors of fluid responsiveness.

Passive Leg Raise (PLR) Test

Elevate legs to 45° while supine (auto-transfusion of ~250–300 mL). Measure CO or pulse pressure change over 1 minute. Reversible — no fluid given.

Positive: CO increase ≥10% or PP increase ≥10% = likely fluid responsive
Requires CO monitoring: oesophageal Doppler, arterial waveform analysis, or echo
Not valid in: high intra-abdominal pressure, patients in upright position

Pulse Pressure Variation (PPV)

Variation in pulse pressure with mechanical ventilation breath cycle. PPV >13% = fluid responsive.

Only valid in: fully mechanically ventilated, sinus rhythm, tidal volume ≥8 mL/kg, no spontaneous breaths
Requires arterial line for continuous waveform analysis
Not valid in arrhythmias, spontaneous breathing, low tidal volumes, or open chest

Mini Fluid Challenge (100–200 mL over 1 min)

Small volume challenge with immediate CO/PP response measurement. Safer than full 500 mL bolus for assessing responsiveness.

10% increase in CO = positive response → give further fluid
Useful in patients with borderline fluid tolerance

Adopt a "fluid-permissive" approach after initial resuscitation. Accumulating fluid excess is associated with worse outcomes (ARDS, abdominal compartment syndrome, prolonged ventilation).

⚠️ Signs of Fluid Overload — Monitor Closely

Rising respiratory rate, falling SpO₂
New or worsening bilateral crackles
Increasing oxygen requirement
Rising CVP (>12–15 cmH₂O)
New or worsening pulmonary infiltrates on CXR

Peripheral pitting oedema, facial/periorbital oedema
Increasing intra-abdominal pressure (>20 mmHg)
Worsening renal function
Positive cumulative fluid balance >10% body weight
Increasing vasopressor requirement despite fluids

💉 Vasopressor Guide

1st

Noradrenaline (Norepinephrine) — FIRST LINE

Alpha-1 dominant vasopressor. Increases SVR with minimal chronotropy. Titrate to MAP ≥65 mmHg.

Starting dose: 0.01–0.05 mcg/kg/min; max 0.5–1 mcg/kg/min (doses >0.25 consider adding hydrocortisone)
Preferred via CVC; peripheral large vein acceptable short-term (ante-cubital or above)
Monitor: MAP (arterial line), HR, peripheral perfusion, capillary refill

2nd

Vasopressin — SECOND LINE (add-on)

Fixed dose: 0.03–0.04 units/min. Non-catecholamine vasopressor. Adds to noradrenaline effect, may allow noradrenaline sparing.

Do NOT titrate vasopressin dose — fixed-dose addition
Evidence: VASST trial — benefit in less severe shock (noradrenaline 5–14 mcg/min)
Avoid in: mesenteric ischaemia, severe CAD without monitoring

3rd

Adrenaline (Epinephrine) — THIRD LINE

Alpha + beta effects. Added when MAP target not achieved despite noradrenaline + vasopressin.

Caution: increases lactate (via beta-2 stimulation of skeletal muscle) — can confound lactate monitoring
Starting dose: 0.05–0.1 mcg/kg/min, titrate to response

Dopamine is NOT recommended in septic shock (2021 SSC). Associated with increased risk of arrhythmias (atrial fibrillation) and higher mortality compared to noradrenaline. Use only if bradycardia is a concern.

🔍 Source Identification

Identifying and controlling the septic source is as important as antimicrobials. Consider all potential sources systematically.

Common Sources

Urinary: UTI, pyelonephritis, obstructed ureter, urosepsis (especially in GCC — high incidence)
Respiratory: Pneumonia (CAP, HAP, VAP), lung abscess, empyema
Intra-abdominal: Appendicitis, cholangitis, peritonitis, ischaemic bowel, diverticular abscess
Skin/Soft Tissue: Necrotising fasciitis, cellulitis, infected pressure injuries
Line-related: CLABSI, infected port, contaminated TPN line
Endocarditis: Consider in IVDU, prosthetic valves, persistent bacteraemia
CNS: Meningitis, epidural abscess (especially post-procedure)

Nurse-Led Source Investigations

Catheter specimen urine (CSU) — if urinary catheter in situ; mid-stream urine (MSU) if not
Sputum culture — induced or spontaneous in intubated/non-intubated patients
Wound swab using Levine technique (press and rotate 5-second swab)
Drain fluid sample — label as drain site, volume, and character
CVC tip culture (≥15 cm of tip) if removing catheter
Stool culture — if diarrhoea, recent antibiotics (C. difficile)
Skin inspection: sacrum, heels, groin folds, IV sites

🔧 Emergency Source Control — Nursing Preparation

Source control (drainage, debridement, device removal) should occur within 6–12 hours of identification. The least invasive approach first.

▸

Abscess Drainage (Bedside or IR)

IV access ×2 patent, fluid running, vasopressors available
Sedation/analgesia prepared and checked (propofol, fentanyl, midazolam as ordered)
Sterile dressing trolley, drain equipment, culture specimen containers ready
Post-procedure: document drain character/volume hourly, send drain fluid for MC&S

▸

Central Line Removal (CLABSI)

Peripheral access established before removal — do not leave patient without IV access
Cut 15 cm of CVC tip aseptically and send for culture (label: CVC tip — right/left side, date)
New CVC insertion: document indication, site, bundle compliance (maximal barrier)
Consider PICC or alternative if prolonged IV therapy needed

▸

Emergency Laparotomy Preparation

Pre-op bloods: FBC, U&E, LFT, coag, group and crossmatch, ABG, lactate
Consent documented, marked surgical site if applicable
Bowel prep if time allows; nil by mouth with timing documented
Haemodynamic stabilisation: MAP ≥65, Hb ≥70 g/L, coagulopathy corrected
Brief briefing with anaesthetic and surgical team on sepsis severity (SOFA score)

🦠 Antibiotic Stewardship in Sepsis

48-hour review is mandatory. When culture results return, narrow antimicrobial spectrum (de-escalate). Continuing broad-spectrum antibiotics beyond culture guidance is harmful (C. difficile, resistance, organ toxicity).

Initial (Empirical) Phase — 0–48 hrs

Cover most likely pathogens for suspected source
Gram-negatives: piperacillin-tazobactam, carbapenems (in high-resistance settings)
MRSA risk: add vancomycin or linezolid
Anaerobic cover: metronidazole or inherent in pip-tazo
Antifungal (echinocandin) if risk factors present

De-escalation Phase — 48–72 hrs

Review all culture results daily with medical team
Narrow to narrowest spectrum agent with documented activity
IV to oral switch when tolerating enteral and clinically improving
Minimum effective duration: 5–7 days for most uncomplicated sources
Procalcitonin trend guides cessation (fall ≥80% from peak)

Procalcitonin-Guided De-escalation

PCT <0.5 ng/mL OR >80% fall from peak → consider discontinuing antibiotics
PCT falling but >0.5 → continue, reassess in 24–48 hours
PCT rising or plateau → review clinical picture, consider treatment failure, new source
PCT less reliable in: immunocompromised, renal failure (impaired clearance)

🍄 Antifungal Therapy — When to Add

Empirical antifungal (echinocandin: caspofungin, micafungin, anidulafungin) should be considered in the following scenarios:

Immunocompromised (haematological malignancy, solid organ transplant, prolonged steroids)
Prolonged ICU stay (>5–7 days) with no improvement on antibacterials
Total parenteral nutrition (TPN) in situ
Multiple broad-spectrum antibiotic courses

Recent abdominal surgery (recurrent perforation/anastomotic leak)
Colonisation with Candida at ≥2 non-contiguous sites
Positive Candida score or Candida risk score ≥3
Persistent candidaemia — escalate to fluconazole if susceptible C. albicans

🩸 Sepsis-Induced Coagulopathy (SIC) / DIC

DIC occurs in up to 35% of septic shock. Activation of coagulation cascade leads to consumptive coagulopathy with both thrombosis and haemorrhage.

Monitoring Parameters

Prothrombin time (PT) / INR — daily
APTT — daily
Fibrinogen — daily (fall <1.5 g/L = severe consumption)
Platelet count — 6–12 hourly if rapidly falling
D-dimer — markedly elevated in DIC
FBC with film — schistocytes suggest TMA/DIC

Transfusion Thresholds (Restrictive Strategy)

RBC: Hb <70 g/L (target 70–90); <80 if active coronary disease
Platelets: <10 (prophylactic); <50 if active bleeding or invasive procedure
FFP: Active bleeding + INR >1.5 / APTT >1.5× normal
Cryoprecipitate: Fibrinogen <1.5 g/L + active bleeding
Do NOT transfuse to normalise lab values alone — clinical context essential

💊 Corticosteroids in Septic Shock — ADRENAL Trial

Indication

Hydrocortisone 200 mg/day (50 mg IV q6h or 200 mg/24hr continuous infusion) when noradrenaline dose ≥0.25 mcg/kg/min persists after adequate resuscitation.

ADRENAL trial (2018): hydrocortisone reduced duration of shock and ICU LOS; no 90-day mortality benefit
APROCCHSS trial (2018): hydrocortisone + fludrocortisone reduced 90-day mortality (NNT ≈ 14)
Monitor glucose closely — steroid-induced hyperglycaemia common; target 7.8–10 mmol/L
Wean hydrocortisone when vasopressors weaning — do not abruptly stop
Relative adrenal insufficiency: random cortisol <276 nmol/L or ACTH stimulation test response <250 nmol/L

Nursing: monitor blood glucose every 1–2 hours when hydrocortisone commenced. Watch for steroid-related complications: hyperglycaemia, GI bleeding, wound healing impairment.

🩺 Glucose Management

Target Range

7.8 – 10 mmol/L
Avoids hypoglycaemia while preventing harm from hyperglycaemia. NICE-SUGAR trial: intensive control (4.5–6 mmol/L) increased mortality.

Hypoglycaemia Protocol

BGL <4 mmol/L = act immediately. 50 mL 50% dextrose IV or 150 mL 10% dextrose. Recheck in 15 min. Document time, value, treatment, and repeat BGL.

Monitoring Frequency

Every 1–2 hours during insulin infusion initiation or dose change
Every 2–4 hours when stable on established insulin infusion
Every 4–6 hours for patients on enteral or parenteral nutrition without insulin infusion
Point-of-care glucometer acceptable; arterial sample if haemodynamically unstable (peripheral capillary unreliable)

🫘 Renal Protection — AKI Prevention

Maintain MAP ≥65 mmHg — renal perfusion pressure dependent on MAP in sepsis
Avoid nephrotoxic drugs: NSAIDs, aminoglycosides (single daily dose if unavoidable + drug levels), iodinated contrast (if urgent imaging, ensure adequate hydration)
Strict fluid balance — avoid both dehydration and fluid overload
Hourly urine output monitoring via IDC — <0.3 mL/kg/hr for 6+ hours = AKI Stage 3
Creatinine/eGFR trend monitoring — rise of ≥26.5 µmol/L in 48 hrs = AKI Stage 1
Review and hold all nephrotoxic medications

Early RRT Criteria

Refractory hyperkalaemia (K >6.5 mmol/L)
Metabolic acidosis pH <7.1 refractory to treatment
Volume overload unresponsive to diuretics with respiratory compromise
Uraemic encephalopathy, pericarditis, or bleeding
Creatinine >350–400 µmol/L with oligoanuria — consider early initiation

🛡️ Supportive Care Bundle

Stress Ulcer Prophylaxis

PPI (pantoprazole 40 mg IV/oral) preferred over H2 blocker in ICU
Indicate ONLY if high-risk: mechanical ventilation >48 hrs, coagulopathy, prior GI bleed, steroid use, renal replacement therapy
Discontinue when risk factors resolve or patient fully enterally fed
H2 blockers (ranitidine) may increase C. difficile risk — use PPI

VTE Prophylaxis

LMWH (enoxaparin) preferred: weight-adjusted dose, renal dose adjustment if CrCl <30
Mechanical (TED stockings + pneumatic compression) if anticoagulation contraindicated (active bleeding, thrombocytopaenia <50)
Review daily — restart pharmacological prophylaxis as soon as safe

Early Enteral Nutrition

Initiate within 24–48 hours if haemodynamically stable (MAP ≥65 on stable/weaning vasopressors)
Start low rate (20–25 mL/hr), advance to goal rate over 24–48 hrs
Monitor gastric residuals if high-risk of aspiration (GCS <8, supine position)
Post-pyloric feeding if high aspiration risk or intolerance
Avoid parenteral nutrition in first 7 days if enteral feasible
Hold enteral nutrition during: prone positioning manoeuvres, active resuscitation with vasopressor escalation, paralytic ileus with vomiting

Sedation Strategy

ABCDEF bundle: Awaken, Breathe, Choice of sedation, Delirium, Early mobility, Family
Light sedation target (RASS 0 to -2) unless specific indications for deeper sedation
Daily sedation holds — document SAT/SBT if mechanically ventilated

🌍 Sepsis in the GCC — Common Sources & Patterns

Leading Sepsis Sources in GCC ICUs

Urinary tract: Highest incidence in GCC (high catheter use, diabetes prevalence, hot climate dehydration). ESBL E. coli and Klebsiella predominant organisms.
Respiratory: VAP rates higher in several GCC centres; community-acquired pneumonia common; Mycobacterium TB must be excluded in migrants.
Intra-abdominal: Perforated peptic ulcer, appendicitis, cholangitis — often late presentations in migrant populations.
Line-related (CLABSI): High CVC utilisation in GCC ICUs; CLABSI rates improving with bundle implementation.

Community-Acquired Sepsis in Migrants

Delayed healthcare-seeking — financial, language, insurance barriers common
TB co-infection: always consider in patients from high-prevalence countries (South Asia, Sub-Saharan Africa). Sputum AFB, IGRA/Mantoux, CXR.
Melioidosis in patients from Southeast Asia (Burkholderia pseudomallei — endemic Thailand, Malaysia)
Enteric fever (Typhoid) — Salmonella typhi; blood cultures positive in 50–80% of cases
Language barriers: use hospital interpreter services — never use family members for consent

🦠 Antibiotic Resistance in GCC

Antimicrobial resistance is a significant and growing concern across GCC healthcare systems, influencing empirical antibiotic selection.

ESBL-Producing Enterobacteriaceae

Extended-spectrum beta-lactamase E. coli and Klebsiella. Resistant to most cephalosporins and penicillins. Empirical carbapenem may be required in high-risk patients (prior ESBL colonisation, healthcare-associated infection).

Carbapenem-Resistant Organisms (CRO/KPC)

Klebsiella pneumoniae carbapenemase (KPC) and NDM-1 increasing in GCC. Very limited treatment options. Consult infectious diseases. Contact precautions + screening of contacts mandatory.

MRSA

Healthcare-associated MRSA prevalent in GCC ICUs. Vancomycin or linezolid required. Monitor vancomycin troughs (target AUC/MIC 400–600 with Bayesian dosing).

Candida Resistance

Fluconazole-resistant C. glabrata and C. krusei increasing. Echinocandin (caspofungin) first-line for candidaemia in GCC ICUs per most institutional protocols.

🕌 Ramadan & Sepsis Recognition

During Ramadan, patients often delay seeking medical care and may present significantly more dehydrated and haemodynamically compromised. A high index of suspicion is required.

Patients may present late with dehydration masking early sepsis signs (compensated tachycardia)
Pre-existing chronic diseases (diabetes, CKD) exacerbated — increased infection risk
Fasting patients: serum lactate and creatinine may be mildly elevated at baseline
Diabetic patients at risk of hypoglycaemia pre-dawn and hyperglycaemia post-iftar — more frequent BGL monitoring required
Altered sleep cycles affect nursing assessment patterns — ensure adequate assessment frequency regardless of time of day
Family presence higher during evening/night — utilise for history, medication reconciliation, discharge education with interpreter

🏥 GCC Sepsis Registries & Awareness Initiatives

KFSHRC (Saudi Arabia)

King Faisal Specialist Hospital & Research Centre — participates in GCC sepsis registry data collection. Published data on sepsis epidemiology and outcomes in Saudi ICUs.

HMC Qatar (Hamad Medical Corporation)

National sepsis protocol implemented across all HMC hospitals. Sepsis alert systems in ED and wards. Active data submission to international registries.

Cleveland Clinic Abu Dhabi

Joint Commission International accredited. Active sepsis quality improvement programme with real-time bundle compliance monitoring and sepsis alert tools.

World Sepsis Day (Sept 13)

Annual awareness campaign globally observed in GCC hospitals. Patient education, staff education sessions, sepsis pledge campaigns. Nurses lead ward-level awareness activities.

👩‍⚕️ Sepsis Six — Nursing-Led Bundle

The UK Sepsis Trust "Sepsis Six" is a simplified nursing-executable bundle to be completed within 1 hour of sepsis recognition. Widely adopted in GCC nursing practice.

Give (3 actions)

🫁 High-flow oxygen — target SpO₂ ≥94% (88–92% if COPD/risk of hypercapnia)
💊 IV antibiotics — broad-spectrum per protocol, within 1 hour
💧 IV fluid challenge — 500 mL crystalloid stat (or weight-based 30 mL/kg)

Take (3 actions)

🩸 Blood cultures — ×2 sets before antibiotics (ANTT)
🧪 Lactate & bloods — FBC, U&E, CRP, blood gas, lactate
🚽 Urine output — catheterise, measure hourly, target ≥0.5 mL/kg/hr

GCC ICU Nurse Sepsis Competency Framework

Recognition: qSOFA scoring, SOFA calculation, early warning system triggers (MEWS/NEWS)
Technical: blood culture ANTT technique, vasopressor preparation and titration, arterial line management
Assessment: fluid balance, urine output trending, haemodynamic monitoring interpretation
Communication: structured handover (ISBAR) with sepsis-specific parameters, escalation protocols
Documentation: bundle timing documentation, medication administration record for antibiotic timing
Family communication: culturally sensitive explanation in Arabic/English/Urdu as required

✅ Sepsis Six Nursing Checklist

Track Sepsis Six completion. Progress is saved locally.

0 / 6 completed

High-flow O₂ applied — SpO₂ documented

Blood cultures ×2 sets collected (ANTT technique)

IV antibiotics administered — time recorded

Lactate and bloods taken (FBC/U&E/CRP/gas)

IV fluid challenge administered — volume documented

Urinary catheter inserted — hourly output monitoring commenced

GCC Nursing Guide — Septic Shock Management